Clinical Trials Logo

Filter by:
NCT ID: NCT03955068 Withdrawn - Ketogenic Diet Clinical Trials

Strict Classic Ketogenic Diet as a Therapy for Recurrent or Progressive and Refractory Brain Tumors in Children

Start date: July 2024
Phase: N/A
Study type: Interventional

This is a pilot study to test the feasibility of implementing a strict classic ketogenic diet among a population of children with recurrent or progressive and refractory brain tumors. Eligible participants will be admitted to the neurosciences floor for 5 days to begin the ketogenic diet either orally, by gastrostomy tube or via nasogastric tube. During the inpatient stay, they will be extensively educated on the diet restrictions and rules. Participants will then continue on the diet at home returning about 17 times over the next 12 months. Daily logs will be kept tracking diet changes, bowel movements and urine ketones. Blood will be collected during the inpatient stay and at all visits for both standard clinical care and research testing.

NCT ID: NCT03953209 Withdrawn - Melasma Clinical Trials

Spironolactone for the Treatment of Melasma

Start date: March 5, 2020
Phase: Phase 1
Study type: Interventional

The purpose of this study is to prospectively gather data on the efficacy and tolerability of spironolactone to treat refractory melasma and to compare treatment response of randomized 50 mg, 100mg, and 200mg per day dosing.

NCT ID: NCT03953170 Withdrawn - Ileostomy - Stoma Clinical Trials

Pilot Study to Investigate the Effect of Teduglutide on Temporary Ileostomy Function and Complications

Start date: June 2, 2022
Phase: Phase 3
Study type: Interventional

The objective of the study is to investigate the natural history of patients with a temporary ileostomy and to assess the effect of Teduglutide in reducing morbidity, hospital readmissions and post reversal complications.

NCT ID: NCT03953027 Withdrawn - Staff Clinical Trials

Understanding the Impact of Drug Shortages on Oncology Care Delivery

Start date: July 1, 2018
Phase:
Study type: Observational

This trial studies the impact of drug shortages on oncology care delivery. Gathering information about cancer drug shortages over time may help researchers improve access to drugs during times of shortages.

NCT ID: NCT03952832 Withdrawn - Clinical trials for Smoldering Plasma Cell Myeloma

Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma

Start date: December 11, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well leflunomide works in treating patients with high-risk smoldering multiple myeloma. Leflunomide may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT03952494 Withdrawn - Depression Clinical Trials

Individualizing Antidepressant Treatment Using Pharmacogenomics and EHR-driven Clinical Decision Support

MyGenes
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to understand the effectiveness of pharmacogenomic testing in using antidepressants and to understand how EHR - driven clinical decision support system can be used to deliver PGx test results by healhcare providers.

NCT ID: NCT03952481 Withdrawn - Dry Eye Clinical Trials

Effect of Lifitegrast 5% on Tear Film Markers

Start date: March 1, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the duration of time (in weeks) for improvement in objective dry eye markers for people who are placed on lifitegrast 0.5% (Xiidra®), an FDA-approved therapy for dry eyes.

NCT ID: NCT03951662 Withdrawn - HIV/AIDS Clinical Trials

Immunology of HIV and Alcoholic Hepatitis

Start date: July 1, 2020
Phase:
Study type: Observational

This is prospective, longitudinal cohort study involving HIV-positive, antiretroviral (ART)-treated, heavy alcohol drinking participants who have and do not have alcoholic hepatitis.

NCT ID: NCT03949842 Withdrawn - Clinical trials for Pulmonary Disease, Chronic Obstructive

Legend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study

LEGEND
Start date: June 27, 2019
Phase: Phase 4
Study type: Interventional

The primary purpose of this study is to assess the effectiveness of TRELEGY ELLIPTA single inhaler triple therapy (SITT) (fluticasone furoate/umeclidinium bromide/vilanterol [FF/UMEC/VI]) relative to non-ELLIPTA multiple inhaler triple therapies (MITT) of inhaled corticosteroids/long-acting beta2-adrenergic receptor agonists/muscarinic receptor antagonists (ICS/LABA/LAMA) within a routine clinical practice setting. This is a non-randomized, interventional and self-controlled cohort study conducted to collect data in routine practice. This study will have two periods where in retrospective data will be collected in pre-switch period and prospective data will be collected in post-switch periods. Subjects will be switched from non-ELLIPTA MITT to TRELEGY ELLIPTA. The pre-switch period is of 52 weeks and post-switch period will be of 52 weeks. Additionally subjects will receive safety follow-up call at 26 weeks and 52 weeks for safety monitoring. Approximately 1300 subjects will be enrolled for this study. TRELEGY ELLIPTA is a registered trademark of the GlaxoSmithKline (GSK) group of companies.

NCT ID: NCT03947671 Withdrawn - Cardiac Surgery Clinical Trials

Active Temperature Management After Cardiac Surgery and Its Effect on Postoperative Cognitive Dysfunction

Start date: January 22, 2020
Phase: Phase 2
Study type: Interventional

This study will assess the effect of active postoperative temperature management and its effect on the cognitive function in patients following coronary artery bypass graft (CABG) surgery to determine if active postoperative temperature management to maintain normothermia reduces postoperative cognitive dysfunction (POCD) in this population. Additionally, the investigators will explore differences in temperature control variability by using temperature management wraps combined with acetaminophen vs. acetaminophen alone in a pilot arm.